222 related articles for article (PubMed ID: 29624682)
1. ABO incompatibility and RhIG immunoprophylaxis protect against non-D alloimmunization by pregnancy.
Zwiers C; Koelewijn JM; Vermij L; van Sambeeck J; Oepkes D; de Haas M; van der Schoot CE
Transfusion; 2018 Jul; 58(7):1611-1617. PubMed ID: 29624682
[TBL] [Abstract][Full Text] [Related]
2. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
[TBL] [Abstract][Full Text] [Related]
3. Passive anti-C acquired in the setting of Rh immune globulin administration following Rh mismatched apheresis platelet transfusion: A case series.
Sostin N; Ross R; Balbuena-Merle R; Hendrickson JE; Tormey CA
J Clin Apher; 2020 Jun; 35(3):224-226. PubMed ID: 32110829
[TBL] [Abstract][Full Text] [Related]
4. Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin.
Rushin J; Rumsey DH; Ewing CA; Sandler SG
Transfusion; 2000 May; 40(5):551-4. PubMed ID: 10827257
[TBL] [Abstract][Full Text] [Related]
5. Reversal of Rh alloimmunization. Fact or fancy?
Bowman JM; Pollock JM
Vox Sang; 1984; 47(3):209-15. PubMed ID: 6087562
[TBL] [Abstract][Full Text] [Related]
6. A cross-sectional study of haemolytic disease of the newborn in Uganda.
Dhabangi A; Nankunda J; Okaba V; Nakubulwa S; Hume HA; Dzik WH; Heddle NM
Vox Sang; 2022 Dec; 117(12):1398-1404. PubMed ID: 36342344
[TBL] [Abstract][Full Text] [Related]
7. Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy.
Aitken SL; Tichy EM
Am J Health Syst Pharm; 2015 Feb; 72(4):267-76. PubMed ID: 25631833
[TBL] [Abstract][Full Text] [Related]
8. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
Karim F; Moiz B; Kamran N
Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years.
Matteocci A; De Rosa A; Buffone E; Pierelli L
Transfus Med; 2019 Jun; 29(3):197-201. PubMed ID: 29369480
[TBL] [Abstract][Full Text] [Related]
10. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility.
Smith HM; Shirey RS; Thoman SK; Jackson JB
Immunohematology; 2013; 29(4):127-30. PubMed ID: 24689681
[TBL] [Abstract][Full Text] [Related]
12. [Changes in feto-maternal incompatibility and the indications for exchange transfusion].
Serrano J
Sangre (Barc); 1991 Dec; 36(6):471-6. PubMed ID: 1667442
[TBL] [Abstract][Full Text] [Related]
13. D+ platelet transfusions in D- patients: cause for concern?
Bartley AN; Carpenter JB; Berg MP
Immunohematology; 2009; 25(1):5-8. PubMed ID: 19856725
[TBL] [Abstract][Full Text] [Related]
14. The routine use of Rh-negative reagent red cells for the identification of anti-D and the detection of non-D red cell antibodies.
Shulman IA; Calderon C; Nelson JM; Nakayama R
Transfusion; 1994 Aug; 34(8):666-70. PubMed ID: 8073481
[TBL] [Abstract][Full Text] [Related]
15. Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin.
Branch DR; Scofield TL; Moulds JJ; Swanson JL
Transfusion; 2011 Apr; 51(4):816-9. PubMed ID: 20946183
[TBL] [Abstract][Full Text] [Related]
16. Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study.
Cid J; Lozano M; Ziman A; West KA; O'Brien KL; Murphy MF; Wendel S; Vázquez A; Ortín X; Hervig TA; Delaney M; Flegel WA; Yazer MH;
Br J Haematol; 2015 Feb; 168(4):598-603. PubMed ID: 25283094
[TBL] [Abstract][Full Text] [Related]
17. Prevention of Rh sensitization in the context of trauma: two case reports.
Werch JB
J Clin Apher; 2010; 25(2):70-3. PubMed ID: 20027640
[TBL] [Abstract][Full Text] [Related]
18. Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor?
de La Rubia J; Arriaga F; Andreu R; Sanz G; Jiménez C; Vicente A; Carpio N; Marty ML; Sanz MA
Transfusion; 2001 Jan; 41(1):106-10. PubMed ID: 11161254
[TBL] [Abstract][Full Text] [Related]
19. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
Lenkiewicz B; Zupańska B
Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
[TBL] [Abstract][Full Text] [Related]
20. [Foetal-maternal alloimmunizations in the South-East area of the Venice province].
Gessoni G; Valverde S; Giacomini A; Antico F; Salvadego M; Arreghini N; De Fusco G; Fezzi M; Marchiori G; Manoni F
Minerva Ginecol; 2002 Aug; 54(4):333-8. PubMed ID: 12114866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
